<DOC>
	<DOCNO>NCT01291082</DOCNO>
	<brief_summary>Prospective MR-imaging study : role magnetic resonance ( MR ) Diffusion weight imaging ( DWI ) MR stag therapy assessment breast cancer patient bone metastasis .</brief_summary>
	<brief_title>Whole-body MR Staging Bone Soft Tissue Metastases Breast Cancer Patients ( MetaMaRBo )</brief_title>
	<detailed_description>About 50 patient proven breast cancer bone metastases include . First step : stag - nuclear bone scan - Positron Emission Tomography ( PET/CT ) - MR ( whole body short tau inversion recovery ( STIR ) -sequence T1-sequence Diffusion weight imaging ( DWI ) , contrast administration Aim : - Validation whole body diffusion weight image detection bone metastases visceral metastasis , compare Bone scan en PET/CT result . - To calculate cut-off value DWI bone visceral metastasis . Second step : therapy follow-up/therapy assessment . - Two group patient ( oncologist take decision therapy ) 1 . Patients treat chemotherapy 2 . Patients treat hormonal therapy - week 3 , 12-16 52 chemotherapy hormonal therapy-setting , whole body MR ( protocol , contrast ) perform . End-point : Whole body MR DWI useful reliable ass treatment response .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Patients proven breast cancer ( biopsy image ) 2 . Bone metastases proven MR , PETCT Bone . Patients visceral metastasis include bone metastasis also present . 3 . Patient informed consent . 1 . Patients single bone metastasis treat Radiotherapy exclude . 2 . Patients contraindication MRI : pacemaker , cochlear implant , non MR compatible device ( Baclofenpump ) . 3 . Claustrophobia 4 . Patient bad general condition .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>metastasis</keyword>
	<keyword>bone</keyword>
	<keyword>diffusion MRI</keyword>
</DOC>